Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph phase_4
1
33%
Ph not_applicable
1
33%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

recruiting267%
unknown133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingphase_4

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

NCT06396078
recruitingphase_3

Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge

NCT06303128
unknownnot_applicable

Safety and Efficacy of an Oral Penicillin Challenge in Low Risk Hospitalized Patients

NCT04408508

Clinical Trials (3)

Showing 3 of 3 trials
NCT06396078Phase 4

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Recruiting
NCT06303128Phase 3

Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge

Recruiting
NCT04408508Not Applicable

Safety and Efficacy of an Oral Penicillin Challenge in Low Risk Hospitalized Patients

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3